NYSEARCA:BBP Virtus LifeSci Biotech Products ETF (BBP) Price, Holdings, & News → Protect Yourself While There’s Still Time … (From Weiss Ratings) (Ad) Free BBP Stock Alerts $52.07 +0.58 (+1.13%) (As of 04/26/2024 ET) Add Compare Share Share Today's Range$52.07▼$52.0750-Day Range$50.60▼$63.3352-Week Range$45.00▼$63.25Volume22 shsAverage Volume3,084 shsMarket Capitalization$18.22 millionAssets Under Management$18.04 millionDividend Yield0.00%Net Expense Ratio0.79% Stock AnalysisStock AnalysisChartHoldingsRatingsStock AnalysisChartHoldingsRatings Get Virtus LifeSci Biotech Products ETF alerts: Email Address About Virtus LifeSci Biotech Products ETFThe Virtus LifeSci Biotech Products ETF (BBP) is an exchange-traded fund that is based on the LifeSci Biotechnology Products index. The fund tracks an index of US-listed biotechnology companies considered to be in the product stage by the index provider. BBP was launched on Dec 17, 2014 and is managed by Virtus.Read More BBP Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart BBP ETF News HeadlinesApril 15, 2024 | finance.yahoo.comSpinnaker ETF Series (OOSP)February 29, 2024 | money.usnews.comAmplify Treatments, Testing and Adv ETFApril 27, 2024 | Weiss Ratings (Ad)Protect Yourself While There’s Still Time …The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.December 22, 2023 | msn.comVirtus LifeSci Biotech Clinical Trials ETF declares annual distribution of $0.0823December 21, 2023 | money.usnews.comiShares Neuroscience and Healthcare ETFDecember 20, 2023 | benzinga.comKey Takeaways From Virtus Inv Analyst RatingsOctober 8, 2023 | benzinga.comVirtus LifeSci Biotech Products ETF (ARCA:BBP), Quotes and News SummaryMarch 15, 2023 | thestreet.comTwo ETF Plays for a Rebound in Biotech StocksApril 27, 2024 | Weiss Ratings (Ad)Protect Yourself While There’s Still Time …The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.February 18, 2023 | benzinga.comVirtus LifeSci Biotech Clinical Trials ETF (ARCA:BBC), Quotes and News SummarySee More Headlines Receive BBP Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Virtus LifeSci Biotech Products ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address Fund Details IssuerVirtus Fund NameVirtus LifeSci Biotech Products ETF Tax ClassificationRegulated Investment Company Stock ExchangeNYSEARCACurrent SymbolNYSEARCA:BBP Inception Date12/16/2014 Fund ManagerMatthew B. Brown, Seth Kadushin WebN/A PhoneN/AFund Focus Asset ClassEquity BenchmarkLifeSci Biotechnology Products Index CategorySector FocusHealth Care Development LevelDeveloped Markets RegionNorth America Number of Holdings57 Fund Statistics Assets Under Management$18.04 million Average Daily Volume$1,551.00 Discount/Premium-0.06% Administrator, Advisor and Custodian AdministratorVirtus ETF Solutions, LLC AdvisorVirtus ETF Advisers LLC CustodianThe Bank of New York Mellon Corporation DistributorETF Distributors LLC Transfer AgentThe Bank of New York Mellon Corporation TrusteeN/A Lead Market MakerVirtu Financial Miscellaneous Outstanding Shares350,004Beta0.85 Creation Unit50,000 Creation Fee$500.00 20 Stocks to Sell NowMarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.Get This Free Report Ad Weiss RatingsProtect Yourself While There’s Still Time …The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.4 simple steps to protect your privacy and money before it’s too late. Virtus LifeSci Biotech Products ETF ExpensesTypeBBPHealth Care ETFsEquity ETFsNYSEARCA ETFsAll ETFsManagement Fee0.79%0.56%0.54%0.50%0.51%Other Expenses0.00%0.40%0.54%0.64%0.58%Total Expense0.79%0.72%0.70%0.74%0.70%Fee Waiver0.00%-0.53%-0.55%-0.68%-0.57%Net Expense0.79%0.60%0.60%0.58%0.58% Virtus LifeSci Biotech Products ETF (BBP) Holdings & ExposureTop 10 BBP HoldingsTarsus Pharmaceuticals(NASDAQ:TARS)Holding Weight: 3.79%ADMA Biologics(NASDAQ:ADMA)Holding Weight: 3.07%Lexicon Pharmaceuticals(NASDAQ:LXRX)Holding Weight: 2.98%Agios Pharmaceuticals(NASDAQ:AGIO)Holding Weight: 2.61%Sarepta Therapeutics(NASDAQ:SRPT)Holding Weight: 2.59%SpringWorks Therapeutics(NASDAQ:SWTX)Holding Weight: 2.54%Ascendis Pharma A/S(NASDAQ:ASND)Holding Weight: 2.51%Moderna(NASDAQ:MRNA)Holding Weight: 2.51%Ligand Pharmaceuticals(NASDAQ:LGND)Holding Weight: 2.44%Neurocrine Biosciences(NASDAQ:NBIX)Holding Weight: 2.25%BBP Sector ExposureBBP Industry ExposureFull Holdings Details Similar ETFsFirst Trust Nasdaq Pharmaceuticals ETFNASDAQ:FTXHHorizon Kinetics Medical ETFNASDAQ:MEDXHarbor Health Care ETFNYSEARCA:MEDIDirexion Daily Pharmaceutical & Medical Bull 3X SharesNYSEARCA:PILLGoldman Sachs Future Health Care Equity ETFNYSEARCA:GDOC BBP ETF - Frequently Asked Questions How have BBP shares performed in 2024? Virtus LifeSci Biotech Products ETF's stock was trading at $58.09 at the beginning of 2024. Since then, BBP stock has decreased by 10.4% and is now trading at $52.0665. View the best growth stocks for 2024 here. What does BBP invest in? Virtus LifeSci Biotech Products ETF is a equity fund issued by Virtus. BBP focuses on health care investments and follows the LifeSci Biotechnology Products Index. The fund's investments total to approximately $18.04 million assets under management. What stocks does Virtus LifeSci Biotech Products ETF hold? BBP invests in 57 holdings. Some of the stocks in their portfolio include Tarsus Pharmaceuticals (TARS), ADMA Biologics (ADMA), Lexicon Pharmaceuticals (LXRX), Agios Pharmaceuticals (AGIO), Sarepta Therapeutics (SRPT), SpringWorks Therapeutics (SWTX), Ascendis Pharma A/S (ASND), Moderna (MRNA), Ligand Pharmaceuticals (LGND) and Neurocrine Biosciences (NBIX). What is the management fee for Virtus LifeSci Biotech Products ETF? Virtus LifeSci Biotech Products ETF's management fee is 0.79% and has no other recorded expenses or fee waivers. The net expense ratio for BBP is 0.79%. What other stocks do shareholders of Virtus LifeSci Biotech Products ETF own? Based on aggregate information from My MarketBeat watchlists, some companies that other Virtus LifeSci Biotech Products ETF investors own include Gilead Sciences (GILD), Inovio Pharmaceuticals (INO), Intel (INTC), Micron Technology (MU), Virtus LifeSci Biotech Clinical Trials ETF (BBC), Quest Diagnostics (DGX), Pfizer (PFE), Simon Property Group (SPG) and Cidara Therapeutics (CDTX). How do I buy shares of Virtus LifeSci Biotech Products ETF? Shares of BBP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NYSEARCA:BBP) was last updated on 4/27/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithFed launches fourth dollar overhaulStansberry ResearchBiden out June 13; Kamala won’t replace him?Paradigm PressMan Who Predicted 2008: “This Will be Worse.”AltimetryJeff Bezos Just Humiliated Elon MuskInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Virtus LifeSci Biotech Products ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
